Unlocking the potential of established products: toward new incentives rewarding innovation in Europe

Unlocking the potential of established products: toward new incentives rewarding innovation in Europe

Background: Many established products (EPs – marketed for eight years or more) are widely used off-label despite little evidence on benefit–risk ratio. This exposes patients to risks related to safety and lack of efficacy, and healthcare providers to liability. Introducing new indications for EPs ma...

Full description

Bibliographic Details
Main Authors:	Gabrielle Nayroles, Sandrine Frybourg, Sylvie Gabriel, Åsa Kornfeld, Fernando Antoñanzas-Villar, Jaime Espín, Claudio Jommi, Nello Martini, Gérard de Pouvourville, Keith Tolley, Jürgen Wasem, Mondher Toumi
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-01-01
Series:	Journal of Market Access & Health Policy
Subjects:	Established products extension of indication new indication repurposing repositioning pricing reimbursement life cycle management
Online Access:	http://dx.doi.org/10.1080/20016689.2017.1298190

Similar Items

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
by: Eric Wen Su, et al.
Published: (2017-03-01)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)

Drug repurposing and market access : conditions and determinants for price, reimbursement and access of reformulated and repositioned drugs in the United States of America and Europe
by: Do Monte Fialho Murteira, Susana Claudia
Published: (2014)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

Exploring different approaches to improve the success of drug discovery and development projects: a review
by: Geoffrey Kabue Kiriiri, et al.
Published: (2020-06-01)

An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)
by: Qiu Ying Lau, et al.
Published: (2015-10-01)

SPIDR: small-molecule peptide-influenced drug repurposing
by: Matthew D. King, et al.
Published: (2018-04-01)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01)

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
by: Noel T Southall, et al.
Published: (2019-10-01)

Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing
by: Shuhei Suzuki, et al.
Published: (2020-08-01)

Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
by: Daiane Dias Ferreira, et al.
Published: (2018-10-01)

Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi
by: Lucie Peyclit, et al.
Published: (2021-05-01)

Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
by: Jennifer Santos, et al.
Published: (2020-06-01)

Editorial: Drug Repurposing
by: Pan Pantziarka, et al.
Published: (2019-07-01)

Drug Repositioning for Effective Prostate Cancer Treatment
by: Beste Turanli, et al.
Published: (2018-05-01)

Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
by: Hosna Mohammad Sadeghi, et al.
Published: (2021-07-01)

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
by: Laura De Lellis, et al.
Published: (2021-08-01)

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
by: Debbie-Ann Shirley, et al.
Published: (2021-03-01)

Changing Trends in Computational Drug Repositioning
by: Jaswanth K. Yella, et al.
Published: (2018-06-01)

A drug repurposing study based on clinical big data for the treatment of interstitial lung disease
by: SONI, SISWANTO
Published: (2020)

Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake
by: Lucas N. Alberca, et al.
Published: (2018-05-01)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
by: Ciska Verbaanderd, et al.
Published: (2020-01-01)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
by: Andrés Pizzorno, et al.
Published: (2019-03-01)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018-06-01)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
by: Vibeke Andresen, et al.
Published: (2017-11-01)

Repurposing Drugs to Treat Heart and Brain Illness
by: Maranda S. Cantrell, et al.
Published: (2021-06-01)

Multi-Data Aspects of Protein Similarity with a Learning Technique to Identify Drug-Disease Associations
by: Satanat Kitsiranuwat, et al.
Published: (2021-03-01)

Indicators of dental caries in teenagers attending various educational establishments
by: Ivanna I. Abramchuk, et al.
Published: (2020-03-01)

The assessment of efficient representation of drug features using deep learning for drug repositioning
by: Mahroo Moridi, et al.
Published: (2019-11-01)

Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01)

Repurposing—a ray of hope in tackling extensively drug resistance in tuberculosis
by: Arundhati Maitra, et al.
Published: (2015-03-01)

Repurposing drugs for the treatment and control of helminth infections
by: Gordana Panic, et al.
Published: (2014-12-01)

Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
by: Anisha S. Jain, et al.
Published: (2021-10-01)

Machine Learning Based Drug-Disease Relationship Prediction and Characterization
by: Yaddanapudi, Suryanarayana
Published: (2019)

Accelerating patient access to oncology medicines with multiple indications in Europe
by: R. Lawlor, et al.
Published: (2021-01-01)

Value added medicines: what value repurposed medicines might bring to society?
by: Mondher Toumi, et al.
Published: (2017-01-01)

InContext: curation of medical context for drug indications
by: Kody Moodley, et al.
Published: (2021-02-01)